Pharmaceutical compositon comprising a cathepsin S inhibitor and an opioid

Details for Australian Patent Application No. 2004233582 (hide)

Owner Novartis AG

Inventors Malcangio, Marzia; Song, Chuanzheng; Ganju, Pamposh

Agent Davies Collison Cave

Pub. Number AU-B-2004233582

PCT Pub. Number WO2004/096227

Priority 60/466,116 28.04.03 US

Filing date 27 April 2004

Wipo publication date 11 November 2004

Acceptance publication date 15 May 2008

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/096227 Priority application(s): WO2004/096227

15 May 2008 Application Accepted

  Published as AU-B-2004233582

11 September 2008 Standard Patent Sealed

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233587-Use of a topical medicament comprising Riluzole

2004233581-Pharmaceutical formulation of the sodium salt of telmisartan